It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Purpose
The purpose of this study was to investigate the relationship between tunnel position in ACL reconstruction (ACL-R) and postoperative meniscus tears.
Methods
This was a single institution, case–control study of 170 patients status-post ACL-R (2010–2019) separated into two matched groups (sex, age, BMI, graft type). Group 1—symptomatic, operative meniscus tears (both de novo and recurrent) after ACL-R. Group 2—no postoperative meniscus tears. Femoral and tibial tunnel positions were measured by 2 authors via lateral knee radiographs that were used to measure two ratios (a/t and b/h). Ratio a/t was defined as distance from the tunnel center to dorsal most subchondral contour of the lateral femoral condyle (a) divided by total sagittal diameter of the lateral condyle along Blumensaat’s line (t). The ratio b/h was defined as distance between the tunnel and Blumensaat’s line (b) divided by maximum intercondylar notch height (h). Wilcoxon sign-ranks paired test was used to compare measurements between groups (alpha set at p < 0.05).
Results
Group 1 had average follow up of 45 months and Group 2 had average follow up of 22 months. There were no significant demographic differences between Groups 1 and 2. Group 1—a/t was 32.0% (± 10.2), which was significantly more anterior than group 2, 29.3% (± 7.3; p < 0.05). There was no difference in average femoral tunnel ratio b/h or tibial tunnel placement between groups.
Conclusions
A relationship exists between more anterior/less anatomic femoral tunnel position and the presence of recurrent or de novo, operative meniscus tears after ACL-R. Surgeons performing ACL-R should strive for recreation of native anatomy via proper tunnel placement to maximize postoperative outcomes.
Level of evidence
Level III.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Pittsburgh Medical Center, UPMC Freddie Fu Sports Medicine Center, Department of Orthopaedic Surgery, Pittsburgh, USA (GRID:grid.412689.0) (ISNI:0000 0001 0650 7433); Sahlgrenska Academy, University of Gothenburg, Department of Orthopaedics, Institute of Clinical Sciences, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582)
2 University of Pittsburgh Medical Center, UPMC Freddie Fu Sports Medicine Center, Department of Orthopaedic Surgery, Pittsburgh, USA (GRID:grid.412689.0) (ISNI:0000 0001 0650 7433)
3 The Hughston Clinic, Fort Walton Beach, USA (GRID:grid.417696.b) (ISNI:0000 0000 9413 275X); The Hughston Foundation, Inc, Columbus, USA (GRID:grid.417696.b)
4 Marquette University, Milwaukee, USA (GRID:grid.259670.f) (ISNI:0000 0001 2369 3143)